Mediclinic International PLC (LON:MDC) had its price objective lowered by stock analysts at Citigroup Inc. from GBX 790 ($10.50) to GBX 720 ($9.57) in a report issued on Wednesday. The brokerage presently has a “neutral” rating on the stock. Citigroup Inc.’s price target would indicate a potential upside of 11.54% from the stock’s previous close.
Other research analysts have also issued reports about the company. Jefferies Group LLC lowered their price objective on Mediclinic International PLC from GBX 650 ($8.64) to GBX 550 ($7.31) and set an “underperform” rating for the company in a research report on Monday, September 25th. Credit Suisse Group reissued a “neutral” rating on shares of Mediclinic International PLC in a research report on Friday, July 21st. Morgan Stanley lowered Mediclinic International PLC to an “equal weight” rating and lowered their price objective for the stock from GBX 825 ($10.96) to GBX 775 ($10.30) in a research report on Thursday, June 29th. Finally, Investec lowered Mediclinic International PLC to a “hold” rating and set a GBX 775 ($10.30) price objective for the company. in a research report on Monday, June 26th. Two research analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. Mediclinic International PLC has an average rating of “Hold” and a consensus price target of GBX 758.13 ($10.07).
Shares of Mediclinic International PLC (MDC) opened at 645.50 on Wednesday. Mediclinic International PLC has a one year low of GBX 632.69 and a one year high of GBX 941.50. The company’s market capitalization is GBX 4.76 billion. The firm has a 50 day moving average price of GBX 701.11 and a 200 day moving average price of GBX 750.29.
Mediclinic International PLC Company Profile
Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.
Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.